Common Contracts
4 similar Senior Unsecured Revolving Credit Agreement contracts by Teva Pharmaceutical Industries LTD
US$2,300,000,000 SENIOR UNSECURED REVOLVING CREDIT AGREEMENT dated as of April 8, 2019 among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V. and TEVA PHARMACEUTICAL FINANCE...Senior Unsecured Revolving Credit Agreement • April 10th, 2019 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This Senior Unsecured Revolving Credit Agreement (this “Agreement” or “Credit Agreement”), dated as of April 8, 2019 is among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim, Jerusalem, Israel (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 1090 Horsham Road, North Wales, Pennsylvania, United States of America (“Teva USA” or the “US Borrower”), TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V., a besloten vennootschap incorporated under the laws of the Netherlands, with its official seat (statutaire zetel) in Amsterdam, the Netherlands and the registered address of which is Piet Heinkade 107, 1019GM Amsterdam, registered with the Dutch trade register under number 853879196 (the “Dutch II Borrower”), TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V., a besloten vennootschap incorporated under the laws of the Netherlands, with
SENIOR UNSECURED REVOLVING CREDIT AGREEMENT dated as of December 18, 2012 among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA FINANCE SERVICES B.V., TEVA FINANCE SERVICES II B.V., and TEVA CAPITAL SERVICES SWITZERLAND...Senior Unsecured Revolving Credit Agreement • December 20th, 2012 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This Credit Agreement (this “Agreement”), dated as of December 18, 2012, is among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim, Jerusalem, ISRAEL (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 1090 Horsham Road, North Wales, Pennsylvania, United States of America (“Teva USA”), TEVA FINANCE SERVICES B.V., a Curaçao company registered under no. 105859 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao I”), TEVA FINANCE SERVICES II B.V., a Curaçao company registered under no. 119570 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao II”), Teva Capital Services Switzerland GmbH, a company organized under the laws of Switzerland, registered under no-320.4.062.063-3 (“Teva Capital”), the Additional Borrowers party hereto from time to time, the Le
AMENDED AND RESTATED SENIOR UNSECURED REVOLVING CREDIT AGREEMENT originally dated as of January 20, 2011 and Amended and Restated as of June 13 2011 among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA FINANCE SERVICES...Senior Unsecured Revolving Credit Agreement • July 28th, 2011 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This Amended and Restated Credit Agreement (this “Agreement”), originally dated as of January 20, 2011 and amended and restated as of June 13, 2011, is among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim, Jerusalem, ISRAEL (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 1090 Horsham Road, North Wales, Pennsylvania, United States of America (“Teva USA”), TEVA FINANCE SERVICES B.V., a Curaçao company registered under no. 105859 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao I”), TEVA FINANCE SERVICES II B.V., a Curaçao company registered under no. 119570 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao II”), Teva Capital Services Switzerland GmbH, a company organized under the laws of Switzerland, registered under no-320.4.062.063-3 (“Tev
3-YEAR SENIOR UNSECURED REVOLVING CREDIT AGREEMENT dated as of January 20, 2011 among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA FINANCE SERVICES B.V., TEVA FINANCE SERVICES II B.V., and TEVA CAPITAL SERVICES...Senior Unsecured Revolving Credit Agreement • February 15th, 2011 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This Credit Agreement (this “Agreement”), dated as of January 20, 2011, is among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim, Jerusalem, ISRAEL (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 1090 Horsham Road, North Wales, Pennsylvania, United States of America (“Teva USA”), TEVA FINANCE SERVICES B.V., a Curaçao company registered under no. 105859 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Finance”), TEVA FINANCE SERVICES II B.V., a Curaçao company registered under no. 119570 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Finance II”), Teva Capital Services Switzerland GmbH, a company organized under the laws of Switzerland, registered under no-320.4.062.063-3 (“Teva Capital”) the Additional Borrowers party hereto from time to time, the Lender
